Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Shane Ward currently holds 34,592 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shane Ward has been a net seller of CDTX stock. They have purchased $9.8K and sold $2.3M worth of shares.
Shane Ward's most recent insider trade was on Dec 10, 2025, when they sold 6,459 shares at $20.20 per share.
Shane Ward serves as Executive at Cidara Therapeutics, Inc. (CDTX). They have executed 26 insider transactions totaling $2.3M over their tenure at the company.
Shane Ward holds the position of Executive at Cidara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Shane Ward has shown a selling trading pattern, with $9.8K in total purchases and $2.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Shane Ward was on Dec 10, 2025, when they sold $3.3M worth of CDTX shares. This transaction involved 15,041 shares at $219.60 per share.
Shane Ward currently owns 34,592 shares of Cidara Therapeutics, Inc. (CDTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Shane Ward's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Shane Ward has 26 Form 4 filings on record as an insider at Cidara Therapeutics, Inc..
Set alerts for Shane Ward and 40,000+ other insiders.